Beacon Investment Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Sell |
23,515
-2,744
| -10% | -$1.44M | 0.54% | 52 |
|
|
2025
Q1 | $16.7M | Buy |
26,259
+1,751
| +7% | +$1.11M | 0.78% | 45 |
|
|
2024
Q4 | $17.5M | Sell |
24,508
-2,678
| -10% | -$1.91M | 0.76% | 49 |
|
|
2024
Q3 | $28.6M | Buy |
27,186
+198
| +0.7% | +$208K | 1.19% | 28 |
|
|
2024
Q2 | $28.4M | Buy |
26,988
+592
| +2% | +$622K | 1.22% | 27 |
|
|
2024
Q1 | $25.4M | Buy |
26,396
+407
| +2% | +$392K | 1.1% | 30 |
|
|
2023
Q4 | $22.8M | Buy |
25,989
+7,523
| +41% | +$6.61M | 1.04% | 31 |
|
|
2023
Q3 | $15.2M | Buy |
18,466
+9,225
| +100% | +$7.59M | 0.75% | 44 |
|
|
2023
Q2 | $6.64M | Buy |
9,241
+566
| +7% | +$407K | 0.31% | 75 |
|
|
2023
Q1 | $7.13M | Buy |
8,675
+54
| +0.6% | +$44.4K | 0.35% | 67 |
|
|
2022
Q4 | $6.22M | Buy |
+8,621
| New | +$6.22M | 0.32% | 71 |
|
|
2020
Q3 | – | Sell |
-325
| Closed | -$203K | – | 263 |
|
|
2020
Q2 | $203K | Buy |
+325
| New | +$203K | 0.01% | 233 |
|
|
2019
Q2 | – | Sell |
-519
| Closed | -$213K | – | 236 |
|
|
2019
Q1 | $213K | Buy |
+519
| New | +$213K | 0.02% | 215 |
|
|
2018
Q4 | – | Sell |
-844
| Closed | -$341K | – | 262 |
|
|
2018
Q3 | $341K | Sell |
844
-6
| -0.7% | -$2.42K | 0.03% | 206 |
|
|
2018
Q2 | $293K | Buy |
850
+3
| +0.4% | +$1.03K | 0.03% | 215 |
|
|
2018
Q1 | $292K | Buy |
847
+30
| +4% | +$10.3K | 0.03% | 220 |
|
|
2017
Q4 | $307K | Sell |
817
-167
| -17% | -$62.8K | 0.03% | 201 |
|
|
2017
Q3 | $440K | Buy |
+984
| New | +$440K | 0.04% | 188 |
|